Ryuk Byun

Ryuk Byun is a seasoned finance professional currently serving as an Executive Director at Morgan Stanley in the San Francisco Bay Area. He has a robust background in investment banking and venture capital, particularly within the healthcare sector.

Professional Background

• Current Role: Executive Director at Morgan Stanley (March 2022 - Present)
• Previous Role: Senior Associate at TCG Crossover (March 2021 - March 2022), where he was part of a team that managed an $824 million biotech crossover fund aimed at investing in public and private drug development companies.123
• Earlier Experience:
  • Associate at Aisling Capital (March 2020 - March 2021)
  • Vice President in Healthcare Investment Banking at Morgan Stanley (January 2019 - March 2020)
  • Associate roles at both Morgan Stanley and Lazard, focusing on healthcare investment banking and mergers & acquisitions.24

Education

• Doctor of Medicine (M.D.) from Tulane University School of Medicine (2009 - 2013)
• Master of Business Administration (MBA) from The University of Chicago Booth School of Business (2013 - 2015)
• Bachelor of Science and Bachelor of Arts in Biochemistry with a specialization in Molecular Genetics and Biology from the University of Virginia (2004 - 2008).2

Skills and Expertise

Ryuk Byun's expertise encompasses:

• Investment strategy in the biotech sector
• Healthcare investment banking
• Mergers and acquisitions
• Financial analysis and corporate finance

His experience and education position him as a knowledgeable leader in the intersection of finance and healthcare innovation.